Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.15 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.036 | 0.7 |